MX2009012233A - Compuestos de triazolil aminopirimidina. - Google Patents

Compuestos de triazolil aminopirimidina.

Info

Publication number
MX2009012233A
MX2009012233A MX2009012233A MX2009012233A MX2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A
Authority
MX
Mexico
Prior art keywords
aminopyrimidine compounds
triazolyl
triazolyl aminopyrimidine
compounds
cancer
Prior art date
Application number
MX2009012233A
Other languages
English (en)
Spanish (es)
Inventor
Jason Scott Sawyer
James Robert Henry
Delu Jiang
Yan Wang
Hong-Yu Li
Harold Burns Brooks
Joyce Z Crich
Melissa Kate Slater
Hong Hu
William Thomas Mcmillen
Sachin Govindlal Maniar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2009012233A publication Critical patent/MX2009012233A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009012233A 2007-05-16 2008-05-07 Compuestos de triazolil aminopirimidina. MX2009012233A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93833307P 2007-05-16 2007-05-16
PCT/US2008/062799 WO2008144222A2 (en) 2007-05-16 2008-05-07 Triazolyl aminopyrimidine compounds

Publications (1)

Publication Number Publication Date
MX2009012233A true MX2009012233A (es) 2009-12-01

Family

ID=39967594

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012233A MX2009012233A (es) 2007-05-16 2008-05-07 Compuestos de triazolil aminopirimidina.

Country Status (15)

Country Link
US (1) US8114872B2 (https=)
EP (1) EP2155735A2 (https=)
JP (1) JP5204838B2 (https=)
KR (1) KR101131254B1 (https=)
CN (1) CN101679396B (https=)
AR (1) AR066472A1 (https=)
AU (1) AU2008254318B2 (https=)
BR (1) BRPI0811611A2 (https=)
CA (1) CA2687474A1 (https=)
CL (1) CL2008001322A1 (https=)
EA (1) EA015574B1 (https=)
MX (1) MX2009012233A (https=)
PE (1) PE20090803A1 (https=)
TW (1) TW200902012A (https=)
WO (1) WO2008144222A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2349169T3 (es) 2006-12-21 2010-12-28 ELI LILLY & COMPANY Compuestos de imidazolidinonil aminopirimidina para el tratamiento del cáncer.
DK2125794T3 (da) 2006-12-21 2011-01-24 Lilly Co Eli Imidazolidinonylaminopyrimidin-forbindelser til behandling af cancer
US8063035B2 (en) 2007-05-16 2011-11-22 Eli Lilly And Company Triazolyl aminopyrimidine compounds
CN101679396B (zh) 2007-05-16 2012-06-06 伊莱利利公司 三唑基氨基嘧啶化合物
CN105121411B (zh) 2013-04-15 2017-10-10 杜邦公司 杀真菌酰胺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) * 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
WO2006021548A1 (de) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
EP1831207B1 (en) 2004-12-17 2012-11-14 Amgen Inc. Aminopyrimidine compounds as plk inhibitors
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
CA2644910C (en) 2006-03-31 2014-01-28 Abbott Laboratories Indazole compounds
ES2349169T3 (es) 2006-12-21 2010-12-28 ELI LILLY & COMPANY Compuestos de imidazolidinonil aminopirimidina para el tratamiento del cáncer.
US8063035B2 (en) * 2007-05-16 2011-11-22 Eli Lilly And Company Triazolyl aminopyrimidine compounds
CN101679396B (zh) 2007-05-16 2012-06-06 伊莱利利公司 三唑基氨基嘧啶化合物

Also Published As

Publication number Publication date
WO2008144222A3 (en) 2009-01-15
CL2008001322A1 (es) 2009-05-22
KR101131254B1 (ko) 2012-04-24
WO2008144222A2 (en) 2008-11-27
CN101679396A (zh) 2010-03-24
AR066472A1 (es) 2009-08-19
TW200902012A (en) 2009-01-16
JP2010527364A (ja) 2010-08-12
CN101679396B (zh) 2012-06-06
EA015574B1 (ru) 2011-10-31
CA2687474A1 (en) 2008-11-27
EA200971067A1 (ru) 2010-04-30
US8114872B2 (en) 2012-02-14
PE20090803A1 (es) 2009-07-11
JP5204838B2 (ja) 2013-06-05
BRPI0811611A2 (pt) 2014-11-04
KR20090130246A (ko) 2009-12-21
EP2155735A2 (en) 2010-02-24
AU2008254318A1 (en) 2008-11-27
AU2008254318B2 (en) 2012-04-05
US20100130466A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
MX2009012228A (es) Compuesto de triazolil aminopirimidina.
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
MY160390A (en) Vinyl indazolyl compounds
IN2012DN00471A (https=)
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
SI2358697T1 (sl) Spojine izoindolina za uporabo pri zdravljenju raka
AP2960A (en) Substituted pyrimidines for the treatment of diseases such as cancer
MX2009009415A (es) Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina.
JO2833B1 (en) Amino pyrazole compound
MY158253A (en) Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
MX2009012233A (es) Compuestos de triazolil aminopirimidina.
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
IL206189A0 (en) Compound for use in the treatment of cancer
MX2011006532A (es) Compuestos anticancerigenos.
WO2008103431A3 (en) Dnai - liposomes
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
IL209005A0 (en) Use of corticotropin-releasing factor for the treatment of cancer
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer
UA29848U (uk) Застосування системної реконструктивної терапії як способу лікування мігрені
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
CY1114071T1 (el) Ενωσεις βινυλοϊνδαζολυλιου
TN2011000545A1 (en) Vinyl indazolyl compounds
ZA200906189B (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer

Legal Events

Date Code Title Description
FG Grant or registration